-
1Academic Journal
Authors: A. P. Gasanbekova, N. A. Lomova, E. L. Dolgopolova, E. V. Titova, T. Eh. Karapetyan, I. I. Ryumina, А. П. Гасанбекова, Н. А. Ломова, Е. Л. Долгополова, Е. В. Титова, Т. Э. Карапетян, И. И. Рюмина
Contributors: The study was conducted with support from the Ministry of Health of the Russian Federation as part of the government assignment (state registration number 121040600408-4)., Исследование выполнено при поддержке государственного задания Министерства здравоохранения Российской Федерации (государственный регистрационный номер 121040600408-4).
Source: Meditsinskiy sovet = Medical Council; № 6 (2023); 172-179 ; Медицинский Совет; № 6 (2023); 172-179 ; 2658-5790 ; 2079-701X
Subject Terms: факторы риска, early and long-term effects, retrospective study, morbidity, risk factors, ранние и отдаленные последствия, ретроспективное исследование, заболеваемость
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/7278/6504; Gordijn S.J., Beune I.M., Thilaganathan B., Papageorghiou A., Baschat A.A., Baker P.N. et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333–339. https://doi.org/10.1002/uog.15884.; Dall’Asta A., Brunelli V., Prefumo F., Frusca T., Lees C.C. Early onset fetal growth restriction. Matern Health Neonatol Perinatol. 2017;3:2. https://doi.org/10.1186/s40748-016-0041-x.; Savchev S., Figueras F., Sanz-Cortes M., Cruz-Lemini M., Triunfo S., Botet F., Gratacos E. Evaluation of an op timal gestational age cut-off for the definition of early- and late onset fetal growth restriction. Fetal Diagn Ther. 2014;36:99–105. https://doi.org/10.1159/000355525.; Kliegman R.M. Intrauterine growth restriction. In: Martin R.J., Fanroff A.A., Walsh M.C. (eds.). Fanaroff and Martin’s Neonatal Perinatal Medicine [M]. 9th ed. Louis, USA: Elsever Mosby; 2011, pp. 245–275.; Longo S., Bollani L., Decembrino L., Di Comite A., Angelini M., Stronati M. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med. 2013;26(3):222. https://doi.org/10.3109/14767058.2012.715006.; Geva R., Eshel R., Leitner Y., Valevski A.F., Harel S. Neuropsychological Outcome of Children With Intrauterine Growth Restriction: A 9-Year Prospective Study. Pediatrics. 2006;18(1):91–100. https://doi.org/10.1542/peds.2005-2343.; Eleftheraddes M., Creatsas G., Nicolaides K. Fetal growth restriction and postnatal development. Ann NY Acad Sci. 2006;1092:319–330. https://doi.org/10.1196/annals.1365.047.; Leitner Y., Fattal-Valevski A., Geva R., Eshel R., Toledano-Alhadef H., Rotstein M. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol. 2007;22(5):580–587. https://doi.org/10.1177/0883073807302605.; Meher S, Lees C. Impact of cerebral redistribution on neurological outcomes in small for gestational age babies: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2014;99(Suppl. 1):A103. https://doi.org/10.1002/uog.14818.; Rueda-Clausen C.F., Morton J.S., Davidge S.T. Effects of hypoxia induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc Res. 2009;81:713–722. https://doi.org/10.1093/cvr/cvn341.; Pylipow M., Spector L.G., Puumala S.E., Boys C., Cohen J., Georgieff M.K. Early postnatal weight gain, intellectual performance, and body mass index at 7 years of age in term infants with intrauterine growth restriction. J Pediatr. 2009;154:201–206. https://doi.org/10.1016/j.jpeds.2008.08.015.; Brown L.D., Rozance P.J., Thorn S.R., Friedman J.E., Hay W.W. Jr. Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep. Am J Physiol Endocrinol Metab. 2012;303(3):E352–364. https://doi.org/10.1152/ajpendo.00059.2012.; Leitner Y., Harel S., Geva R., Eshel R., Yaffo A., Many A. The neurocognitive outcome of IUGR children born to mothers with and without preeclampsia. J Matern Fetal Neonatal Med. 2012;25(11):2206–2208. https://doi.org/10.3109/14767058.2012.684164.; Salam R.A., Das J.K., Anum A., Lassi Z., Bhutta Z. et al. Maternal undernutrition and intrauterine growth restriction. Expert Rev Obstet Gynecol. 2013;8(6):559–567. https://doi.org/10.1586/17474108.2013.850857.; Maršál K. Physiological adaptation of the growth-restricted Fetus. Best Pract Res Clin Obstet Gynaecol. 2018;49:37–52. https://doi.org/10.1016/j.bpobgyn.2018.02.006.; Martins J.G., Biggio J.R., Abuhamad A. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol. 2020;223(4):B2-B17. https://doi.org/10.1016/j.ajog.2020.05.010.; Balogun O.A., Khanagura R.K., Kregel H.R., Amro F.H., Sibai B.M., Chauhan S.P. Preterm Preeclampsia with Severe Features: Composite Maternal and Neonatal Morbidities Associated with Fetal Growth Restriction. Am J Perinatol. 2018;35(8):785–790. https://doi.org/10.1055/s-0037-1617456.; Spinillo A., Cesari S., Bariselli S., Tzialla C., Gardella B., Silini E.M. Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies. Placenta. 2015;36(5):538–544. https://doi.org/10.1016/j.placenta.2015.02.007.; Saravanan P; Diabetes in Pregnancy Working Group; Maternal Medicine Clinical Study Group; Royal College of Obstetricians and Gynaecologists, UK. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol. 2020;8(9):793–800. https://doi.org/10.1016/s2213-8587(20)30161-3.; Briana D.D., Fotakis Ch., Kontogeorgou A., Gavrili S., Georgatzi S., Zoumpoulakis P., Malamitsi-Puchner A. Early Human-Milk Metabolome in Cases of Intrauterine Growth – Restricted and Macrosomic Infants. JPEN J Parenter Enteral Nutr. 2020;44(8):1510–1518. https://doi.org/10.1002/jpen.1783.; Albu A.R., Anca A.F., Horhoianu V.V., Horhoianu I.A. Predictive factors for intrauterine growth restriction. J Med Life. 2014;7(2):165–171. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197512.; Blue N.R., Page J.M., Silver R.M. Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies. Obstet Gynecol Clin North Am. 2021;48(2):419–436. https://doi.org/10.1016/j.ogc.2021.03.002.; Longo S., Bollani L., Decembrino L., Di Comite A., Angelini M., Stronati M. Short-term and long-term sequelae in intrauterine growth retardation. J Matern Fetal Neonatal Med. 2013;26:222–225. https://doi.org/10.3109/14767058.2012.715006.; Рюмина И.И., Маркелова М.М., Нароган М.В., Орловская И.В., Перепелкина А.Е., Рындин А.Ю. и др. Опыт внедрения международных стандартов оценки роста новорожденного INTERGROWTH-21st. Российский вестник перинатологии и педиатрии. 2021;66(1):117–124. https://doi.org/10.21508/1027-4065-2021-66-1-117-124.; Liu J., Wang X.F., Wang Y., Wang H.W., Liu Y. The incidence rate, high-risk factors, and short- and long-term adverse outcomes of fetal growth restriction: a report from Mainland China. Medicine (Baltimore). 2014;93(27):e210. https://doi.org/10.1097/MD.0000000000000210.
-
2Academic Journal
Authors: Кочерова, Виктория, Щербак, Владимир
Subject Terms: АДЕРЖКА ВНУТРИУТРОБНОГО РАЗВИТИЯ, МЛАДЕНЦЫ, НОВОРОЖДЕННЫЕ, ПОЛИМОРФИЗМ ГЕНОВ, РАННИЕ И ОТДАЛЕННЫЕ ПОСЛЕДСТВИЯ
File Description: text/html
-
3Academic Journal
Source: Российский педиатрический журнал.
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, АДЕРЖКА ВНУТРИУТРОБНОГО РАЗВИТИЯ, МЛАДЕНЦЫ, НОВОРОЖДЕННЫЕ, ПОЛИМОРФИЗМ ГЕНОВ, РАННИЕ И ОТДАЛЕННЫЕ ПОСЛЕДСТВИЯ, 3. Good health
File Description: text/html
